Thu 28 13:42
OC5.3
Thu 28 10:20
OC4.9
Health Status of Children Aged 8-18 Years with 21-Hydroxylase Deficiency in the United Kingdom: Results of a Multi-Centre Cohort Study
Oxford, UK
Thu 28 14:24
OC5.10
Review of neonatal cortisol evaluation between 2012-2018 in a single centre: trends, outcomes and associations.
Oxford, UK
UK
Thu 28 09:10
OC4.2
Burosumab Initiation in a UK XLH Cohort: Real-World Use Resonates With Research Evidence
UK
Bristol, UK
Thu 28 10:00
OC4.7
Novel variants in the Leucine-zipper-like transcription regulator 1 (LZTR1) gene cause Noonan syndrome phenotype by upregulation of the RAS-MAPKinase pathway
Bristol, UK
Newcastle, UK
London, UK
Thu 28 09:40
OC4.5
Novel genetic defects in a cohort of Silver-Russell Syndrome (SRS) and SRS-like patients
London, UK
London, UK
Cardiff`, UK
Thu 28 09:50
OC4.6
Understanding Differences of Sexual Differentiation (DSD) MDT services across the UK; current service provision and sharing best practice
Cardiff`, UK
Southampton, UK
London, UK
Thu 28 09:20
OC4.3
Defects in LGR4 Wnt-β-catenin signalling impair GnRH network development, leading to delayed puberty
London, UK
Southport , UK
Thu 28 13:36
OC5.2
Longitudinal outcomes of well, term infants who present with persistent hyperthyrotropinaemia
Southport , UK
Thu 28 14:06
OC5.7
Longitudinal Changes in External Masculinisation Scores in Boys Born with XY Disorders of Sex Development
Thu 28 09:30
OC4.4
A Novel Clinical Risk Score That Accurately Predicts Recurrence of Craniopharyngioma - a Multicentre Cohort Study.
Thu 28 14:12
OC5.8
TSH-Receptor testing in pregnancy allows stratification of risk of neonatal thyrotoxicosis and promotes earlier discharge
Thu 28 10:10
OC4.8
SGPL1 deficiency leads to accumulation of sphingolipid species and downregulation of key enzymes within the steroidogenic pathway
London, UK
Thu 28 13:54
OC5.5
Recombinant human Insulin-like growth factor-1 (rhIGF-1) therapy: a 15-year experience in a tertiary care centre
London, UK
Thu 28 14:18
OC5.9
Cardiff University, United Kingdom
Thu 28 11:00
S1.1
Thu 28 11:30
S1.2
Have modern treatment regimens improved neuroendocrine and cognitive outcomes after childhood brain tumours ?
Sheffield, UK
Thu 28 07:45
Fluid restriction in the management DKA in an intensive care setting - has the pendulum swung too far?
Sheffield, UK
Thu 28 14:00
OC5.6
Monitoring and long-term disease activity in children with X-linked hypophosphataemia on conventional therapy
Thu 28 09:45
PENS1.1
Oxford, United Kingdom
Thu 28 13:30
OC5.1
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation Testing (GST) in Children and Adolescents
Sheffield
Thu 28 08:15
Management of DKA - Evidence and Consensus recommendations for the proposed changes to the management of DKA and to the BSPED Guidelines
Sheffield
Workshop
0
Oral
2
Expert
0
Plenary
0
Catering and Social
3
Nurse
1
Other
5
Symposium
2
No Session Type
2
Thu 28 09:10
OC4.2
Burosumab Initiation in a UK XLH Cohort: Real-World Use Resonates With Research Evidence
UK
Thu 28 09:20
OC4.3
Defects in LGR4 Wnt-β-catenin signalling impair GnRH network development, leading to delayed puberty
London, UK
Thu 28 09:30
OC4.4
A Novel Clinical Risk Score That Accurately Predicts Recurrence of Craniopharyngioma - a Multicentre Cohort Study.
Thu 28 09:40
OC4.5
Novel genetic defects in a cohort of Silver-Russell Syndrome (SRS) and SRS-like patients
London, UK
Thu 28 09:50
OC4.6
Understanding Differences of Sexual Differentiation (DSD) MDT services across the UK; current service provision and sharing best practice
Cardiff`, UK
Thu 28 10:00
OC4.7
Novel variants in the Leucine-zipper-like transcription regulator 1 (LZTR1) gene cause Noonan syndrome phenotype by upregulation of the RAS-MAPKinase pathway
Bristol, UK
Thu 28 10:10
OC4.8
SGPL1 deficiency leads to accumulation of sphingolipid species and downregulation of key enzymes within the steroidogenic pathway
Thu 28 10:20
OC4.9
Health Status of Children Aged 8-18 Years with 21-Hydroxylase Deficiency in the United Kingdom: Results of a Multi-Centre Cohort Study
Thu 28 13:30
OC5.1
Project to Develop BSPED UK Standardised Guidelines for Sex Hormone Priming and Glucagon Stimulation Testing (GST) in Children and Adolescents
Thu 28 13:36
OC5.2
Longitudinal outcomes of well, term infants who present with persistent hyperthyrotropinaemia
Southport , UK
Thu 28 13:42
OC5.3
Thu 28 13:54
OC5.5
Recombinant human Insulin-like growth factor-1 (rhIGF-1) therapy: a 15-year experience in a tertiary care centre
London, UK
Thu 28 14:00
OC5.6
Monitoring and long-term disease activity in children with X-linked hypophosphataemia on conventional therapy
Thu 28 14:06
OC5.7
Longitudinal Changes in External Masculinisation Scores in Boys Born with XY Disorders of Sex Development
Thu 28 14:12
OC5.8
TSH-Receptor testing in pregnancy allows stratification of risk of neonatal thyrotoxicosis and promotes earlier discharge
Thu 28 14:18
OC5.9
Thu 28 14:24
OC5.10
Review of neonatal cortisol evaluation between 2012-2018 in a single centre: trends, outcomes and associations.
Oxford, UK
Thu 28 11:00
S1.1
Thu 28 11:30
S1.2
Have modern treatment regimens improved neuroendocrine and cognitive outcomes after childhood brain tumours ?
0 result(s) found.